Nik Deogun, senior vice president and editor in chief at CNBC, sent out the following announcement on Thursday:
I am pleased to announce that Meg Tirrell will join CNBC as a general assignment reporter, effective April 7th. Meg’s primary focus will be covering the biotechnology and pharmaceutical beat and will appear on both CNBC’s Business Day programming and CNBC.com.
Meg comes to us from Bloomberg News, which she joined in 2007. At Bloomberg News, she led the coverage of the biotechnology industry and reported on big merger & acquisition stories, including Amylin Pharmaceuticals and Genzyme, proxy fights at Forest Labs and Vivus as well as important FDA decisions. She also contributed to Bloomberg Television and Bloomberg Businessweek.
Meg holds a master’s degree in journalism from Northwestern University and a bachelor’s degree in English and music from Wellesley College.
Please join me in welcoming Meg to CNBC.
